Yoshio Taguma1, Shigemi Chiba, Hiroshi Sato
1Department of Nephrology, Sendai Shakaihoken Hospital.
Membranoproliferative glomerulonephritis (MPGN) presents unique histological features and can be primary or secondary. Treatment involves pathogen exclusion and managing autoimmune mechanisms for this kidney disease.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: